Why is the Fetal Heart Monitoring Market Important?
Over 85% of the 4,100,000 live births occurring in the US during 2011 required fetal monitoring during labor and delivery. Current non-invasive Doppler, employing ultrasound to detect fetal heart rate is subject to loss of fetal heart rate due to maternal/fetal movement. Fetal Scalp Electrodes that connect directly to the fetus during the later stages of labor and delivery are associated with increased risk of maternal/fetal infection. There are an estimated 28,000 fetal monitors spread over 3,400 hospitals in the US, representing an investment of over $700,000,000.
MindChild Medical, Inc., is a Pioneer in the Development of Non-Invasive Fetal Monitoring
MERIDIAN has been developed to provide uninterruptible fetal electrocardiograph data while addressing the deficiencies in both Doppler and FSE via innovative non-invasive monitoring technology. The MERIDIAN non-invasive fetal electrocardiograph monitor is designed to report fetal heart rate data equivalent to the gold standard fetal scalp electrode in addition to novel ECG metrics intended to provide obstetricians a deeper understanding of fetal/maternal health and management.
The MERIDIAN Non-Invasive Fetal Heart Rate Monitor
MERIDIAN is a fetal monitor that non-invasively measures and displays fetal heart rate. MERIDIAN acquires and displays the FHR tracing from abdominal surface electrodes that detect the fetal ECG signal. MERIDIAN may also be used to measure and display fetal heart rate using direct ECG with a Fetal Scalp Electrode. MERIDIAN is designed for women who are at term (> 36 completed weeks), in labor, with singleton pregnancies, using surface electrodes on the maternal abdomen. MERIDIAN is intended for use by healthcare professionals in a clinical setting.
About MindChild Medical, Inc.
MindChild Medical, Inc., is a privately funded medical device company founded in 2008. MindChild was co-founded by Adam Wolfberg, MD, Assistant Professor, Tufts Medical Center, Gari Clifford, PhD, previously Principal Research Scientist at Harvard-MIT Division of Health and Science Technology (currently on the faculty at the University of Oxford in the Department of Engineering Science), James Robertson, President and CEO, and Jay Ward, Executive Vice President, both of E-TROLZ, Inc. MindChild has exclusively licensed intellectual property from the Massachusetts Institute of Technology, Tufts Medical Center and E-TROLZ, Inc., a Massachusetts technology company that develops and commercializes breakthrough physiologic monitoring platforms for a wide variety of applications.
2011 AJOG Clinically Accurate Fetal ECG Article
2011 SMFM TR Poster
2010 SMFM ST Poster
2010 SMFM Entropy Poster
2010 SMFM FHR Abdomen FSE Poster
2009 Fetal ECG Device Development Poster
2008 Journal MFNM FHR Variability Article